eRegister's captcha

Patent Register Details

Print page icon Print this page

PATENT REGISTER
A Supplementary Protection Certificate (SPC) exists for this Patent. To view the SPC Details click following SPC number(s): 2018/002
Status Granted Patent No. 2515855
Application No. 10799030.1 Date of Filing 22/12/2010
Date Grant Published 02/04/2014 Application Published 31/10/2012
Title of Invention Combination therapy for COPD
Priority
Priority Country Filing Date Application No.
 European Patent Office (EPO)  23/12/2009  09180671
Inventors BONELLI, Sauro
USBERTI, Francesca
ZAMBELLI, Enrico
Current Proprietor Chiesi Farmaceutici S.p.A.
Via Palermo, 26/A
43100 Parma
ITALY
Address for service TOMKINS & CO.
5 Dartmouth Road
Dublin 6
IRELAND
Renewal Fees
Year Date Renewed
 16  29/12/2025
 15  27/12/2024
 14  27/12/2023
 13  27/12/2022
 12  27/12/2021
 11  28/12/2020
 10  27/12/2019
 9  27/12/2018
 8  28/12/2017
 7  29/12/2016
 6  31/12/2015
 5  29/12/2014
Publication Language English
Translation Received Date
09/06/2014 Address for Service recorded as TOMKINS & CO., 5 Dartmouth Road, Dublin 6, Ireland received on 06/06/2014.
16/01/2018 Request for grant a Supplementary Protection Certificate, citing Patent number 2515855 as the relevant basic patent, in respect of the product A combination of glycopyrronium bromide, formoterol or a salt thereof and beclometasone dipropionate. filed on 10/01/2018. Reference number of request is 2018/002.
25/07/2019 Supplementary Protection Certificate Number 2018/002, having an expiry date of 18/07/2032 granted on 25/07/2019.
12/01/2023 Request for limitation of patent specification filed on 07/12/2022
04/05/2023 Request for limitation of patent specification allowed on 21/03/2023